Tag: Trailblazers in Health Professions

Carrinna Hansen | Health Professions | Best Researcher Award

Published on by World Science Awards

Assoc. Prof. Dr. Carrinna Hansen | Health Professions | Best Researcher Award

Dept. of Orthopaedic Surgery at Zealand University Hospital, Denmark

Dr. Carrinna Aviaja Hansen is an accomplished Associate Professor and Research Manager with an extensive background in nursing and health sciences. She has been at the forefront of clinical and academic research for over 15 years, focusing on improving patient outcomes and advancing family-centered care in healthcare. As a recognized expert, Dr. Hansen’s contributions include numerous publications, supervision of graduate students, and securing significant research funding. Her expertise spans chronic diseases, diabetic foot ulcers, chronic pain, and orthopedic surgery, and her work emphasizes patient and family involvement in care processes. Dr. Hansen’s leadership roles in professional societies and her dedication to teaching and mentorship highlight her commitment to shaping the future of healthcare research.

Professional Profile

Education

Dr. Hansen’s academic journey reflects a strong commitment to excellence and lifelong learning. She earned her PhD in Health Sciences from the University of Southern Denmark in 2014, followed by a Master of Public Health from the University of Copenhagen in 2007. Her earlier educational milestones include a Bachelor’s degree in Nursing from Aarhus University and a registered nurse certification in 1998. Additionally, Dr. Hansen has completed over 25 research-related courses and workshops, including statistics, science communication, and university pedagogy, enhancing her technical and teaching competencies. This diverse academic foundation has prepared her for impactful research and leadership roles in healthcare.

Professional Experience

Dr. Hansen’s professional career showcases a rich blend of clinical practice, research management, and academic appointments. Currently an Associate Professor at the University of Southern Denmark, she also serves as a Research Manager at Zealand University Hospital. Her earlier roles include Postdoctoral Fellow, Consulting Nurse, and Clinical Nurse Specialist across various hospitals in Denmark. She has also held external teaching positions at the University of Copenhagen and Aarhus University. Throughout her career, Dr. Hansen has led research projects, facilitated workshops, and supervised numerous graduate students, reflecting her versatility and leadership in healthcare. Her experience spans nursing, chronic disease management, and interdisciplinary collaboration.

Research Interests

Dr. Hansen’s research interests focus on patient-centered and family-centered care in healthcare. Her work addresses critical issues in chronic disease management, such as diabetic foot ulcers, chronic pain, and osteoporosis. She is particularly passionate about integrating patients and their families into care processes to improve outcomes. Dr. Hansen also explores orthopedics, epidemiology, and qualitative methodologies, including focus group interviews and thematic analysis. Her commitment to translating research into practice ensures that her findings directly impact clinical care and patient well-being. This multidisciplinary approach underscores her dedication to advancing healthcare systems and improving the quality of life for patients.

Research Skills

Dr. Hansen possesses a comprehensive skill set encompassing both qualitative and quantitative research methodologies. Her expertise includes cohort studies, register-based research, thematic analysis, and phenomenological-hermeneutic approaches. She is proficient in conducting focus group and individual interviews, developing patient-reported outcome measures, and implementing complex research protocols. Additionally, Dr. Hansen has extensive experience in project management, grant writing, and research supervision. Her ability to blend methodological rigor with practical application ensures the success of her research endeavors and her contributions to healthcare improvement.

Awards and Honors

Dr. Hansen’s dedication and excellence have earned her several prestigious awards. In 2023, she received the Best Abstract and Best Poster awards for her research on diabetic foot ulcers and family involvement in patient care. Earlier, in 2018, her study on chronic pain won Best Poster at Rigshospitalet’s Neuroscience Center Research Day. Beyond these accolades, Dr. Hansen has held honorary positions in esteemed professional societies and advisory boards, further cementing her reputation as a leader in healthcare research and development.

Conclusion

Dr. Carrinna Aviaja Hansen exemplifies excellence in research, education, and leadership. Her academic achievements, extensive professional experience, and impactful research contributions position her as a leading figure in healthcare innovation. Through her dedication to teaching, mentorship, and patient-centered care, she continues to influence the future of nursing and health sciences. With her robust skill set and unwavering commitment, Dr. Hansen is a deserving candidate for recognition in research excellence.

Publication Top Notes

  1. Title: Patient involvement in diabetes-related foot ulcers: What do patients need and prefer when undergoing treatment at multidisciplinary outpatient foot centres? A phenomenological hermeneutic study
    Authors: Hansen, C.A.; Hjelmgaard, C.M.H.; Kristensen, M.Ø.; Berthelsen, C.
    Year: 2024
  2. Title: SHOULD I STAY OR SHOULD I GO–A rapid qualitative study of principal deteriorating factors experienced by nurses relating to their intentions to leave their current position in a medical hospital department
    Authors: Berthelsen, C.; Hansen, C.A.
    Year: 2024
    Citations: 1
  3. Title: Factors Associated With Time to Decannulation in Patients With Tracheostomy Following Severe Traumatic Brain Injury
    Authors: Eskildsen, S.J.; Hansen, C.A.; Kallemose, T.; Wessel, I.; Poulsen, I.
    Year: 2024
    Citations: 1
  4. Title: Content and Effect of Introduction Programmes to Increase Retention and Decrease Turnover of Newly Graduated Nurses in Hospitals: Umbrella Review
    Authors: Berthelsen, C.; Hansen, C.
    Year: 2024
  5. Title: The Effect of Family Nursing Conversations as an Add-on to Multidisciplinary Treatment in Patients with Chronic Non-Cancer Pain: A Quasi-Experimental Trial
    Authors: Rønne, P.F.; Esbensen, B.A.; Brødsgaard, A.; Sørensen, B.-B.; Hansen, C.A.
    Year: 2024
  6. Title: Essential factors influencing registered nurses to stay in their position at a university hospital medical department: A rapid qualitative research study
    Authors: Berthelsen, C.; Kjærgaard, K.M.; Hansen, C.A.
    Year: 2024
    Citations: 2
  7. Title: Rehabilitative intervention for successful decannulation in adult patients with acquired brain injury and tracheostomy: a systematic review
    Authors: Eskildsen, S.J.; Wessel, I.; Poulsen, I.; Hansen, C.A.; Curtis, D.J.
    Year: 2024
    Citations: 1
  8. Title: Barriers and Facilitators Influencing Nurses’ Confidence in Managing Family Nursing Conversations in the Treatment of Chronic Noncancer Pain: A Longitudinal Qualitative Study
    Authors: Rønne, P.F.; Esbensen, B.A.; Brødsgaard, A.; Voltelen, B.; Hansen, C.A.
    Year: 2023
    Citations: 3
  9. Title: Epidemiological Factors Associated with Prescription of Opioids for Chronic Non-Cancer Pain in Adults: A Country-Wide, Registry-Based Study in Denmark Spans 2004–2018
    Authors: Hansen, C.A.; Abrahamsen, B.; Ernst, M.T.; Smith, C.D.
    Year: 2023
    Citations: 4
  10. Title: Patients’ and Family Members’ Experiences of a Novel Nurse-Led Intervention Using Family Conversations Targeting Families Afflicted by Chronic Non-Cancer Pain
    Authors: Rønne, P.F.; Esbensen, B.A.; Brødsgaard, A.; Biering-Sørensen, B.; Hansen, C.A.
    Year: 2023
    Citations: 2

 

Dengju Li | Health Professions | Best Researcher Award

Published on by World Science Awards

Mr. Dengju Li | Health Professions | Best Researcher Award

Professor at Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China

Prof. Li Dengju is a distinguished researcher and academician in the field of hematology, specializing in acute leukemia. With over 22 years of professional experience, he currently serves as a Professor and Chief Physician in the Department of Hematology at Tongji Hospital, affiliated with Huazhong University of Science and Technology. His research has significantly contributed to the understanding of hematological disorders, with a particular focus on DNMT3A-mutated acute myeloid leukemia (AML). Prof. Dengju is an accomplished mentor, guiding six doctoral and over 20 master’s students, and has published 35 high-impact SCI papers as the first or corresponding author. His innovative findings on CAR-T therapy for AML underline his dedication to advancing personalized immunotherapy. Prof. Dengju’s contributions to clinical research include participation in over 60 international and domestic clinical studies, demonstrating his expertise in translating scientific discoveries into clinical practice.

Professional Profile

Education

Prof. Dengju’s academic journey began with a bachelor’s degree in medicine from Henan Medical University in 1996. He pursued a doctorate in hematology at Huazhong University of Science and Technology, completing it in 2002. His educational background has provided a strong foundation for his groundbreaking research in acute leukemia. As a lifelong learner, Prof. Dengju continuously enriches his knowledge through research and collaborations. Notably, his tenure as a visiting scholar at the University of Pennsylvania School of Medicine from 2010 to 2011 expanded his global academic perspective. These experiences have equipped him with advanced skills in research methodologies, clinical practices, and innovative treatments for hematological disorders. His dedication to academic excellence has been a driving force behind his successful career in both education and research.

Professional Experience

Prof. Dengju began his professional journey as a Deputy Chief Physician and Associate Professor in the Department of Hematology at Tongji Hospital in 2004. Over the years, he has risen to the position of Chief Physician and full Professor, a role he has held since 2011. His leadership in the department has been pivotal in advancing research and clinical care for patients with acute leukemia. In addition to his academic role, Prof. Dengju actively engages in clinical trials, serving as the principal investigator for numerous national and provincial projects. His tenure as a visiting scholar at the University of Pennsylvania further enriched his expertise, enabling him to incorporate international best practices into his work. Through his career, he has combined academic rigor with clinical excellence, making substantial contributions to the field of hematology.

Research Interests

Prof. Dengju’s primary research interests lie in acute leukemia, with a specific focus on DNMT3A-mutated AML. His team’s work explores the molecular mechanisms of this mutation and its impact on the immune microenvironment, leading to groundbreaking discoveries in personalized immunotherapy. His innovative research on CD44v6 CAR-T therapy has opened new avenues for targeted treatments, providing hope for patients with this challenging condition. Prof. Dengju is deeply committed to advancing knowledge in the diagnosis, treatment, and management of hematological disorders. His collaborative approach integrates basic and clinical research, aiming to bridge the gap between laboratory findings and patient care. By focusing on precision medicine, he seeks to develop novel therapies that improve outcomes for leukemia patients worldwide.

Research Skills

Prof. Dengju possesses a comprehensive skill set in hematology research, including advanced diagnostic techniques, molecular biology, and immunotherapy development. His expertise extends to designing and managing large-scale clinical trials, evidenced by his involvement in over 60 studies of new drugs for leukemia. He is adept at grant writing and has successfully secured funding for multiple national and provincial research projects. As a seasoned academic, he excels in mentoring and supervising doctoral and master’s students, fostering the next generation of researchers. His proficiency in publishing high-impact papers reflects his ability to communicate complex scientific findings effectively. Prof. Dengju’s collaborative mindset and interdisciplinary approach enable him to contribute significantly to both basic and translational research in hematology.

Awards and Honors

Throughout his career, Prof. Dengju has received numerous accolades for his contributions to hematology. He has been recognized for his leadership in research and his role in advancing clinical treatments for acute leukemia. His publications in high-impact journals and his successful mentoring of doctoral and master’s students have earned him respect within the academic community. While specific awards and honors are not listed in his application, his achievements in securing competitive research funding and his appointment as a visiting scholar at the University of Pennsylvania highlight his international recognition. Prof. Dengju’s dedication to innovation and excellence in hematology research has established him as a prominent figure in his field.

Conclusion

Prof. Li Dengju is an exemplary candidate for the Best Researcher Award, given his extensive experience, groundbreaking research, and commitment to academic excellence. His innovative work on DNMT3A-mutated AML and CAR-T therapy demonstrates his ability to address critical challenges in hematology. As a leader, mentor, and researcher, Prof. Dengju embodies the qualities of a distinguished scientist dedicated to advancing medical knowledge and improving patient care. His accomplishments not only reflect his expertise but also his unwavering commitment to making meaningful contributions to the scientific community. Prof. Dengju’s remarkable career trajectory and impactful research make him highly deserving of this prestigious recognition.

Publication Top Notes

  • Global, regional, and national burden of acute myeloid leukemia, 1990–2021: a systematic analysis for the global burden of disease study 2021
    • Authors: Yeming Zhou, Guiqin Huang, Xiaoya Cai, Ying Liu, Bingxin Qian, Dengju Li
    • Year: 2024
    • DOI: 10.1186/s40364-024-00649-y
    • Citations: As this article was published in 2024, citation data may not be available yet.
  • XPO1 inhibition displays anti-leukemia efficacy against DNMT3A-mutant acute myeloid leukemia via downregulating glutathione pathway
    • Authors: Xiaoya Cai, Ying Liu, Huimin Li, Yimei Que, Min Xiao, Ying Wang, Xiong Wang, Dengju Li
    • Year: 2024
    • DOI: 10.1007/s00277-024-05706-y
    • Citations: As this article was published in 2024, citation data may not be available yet.
  • Significance of targeting DNMT3A mutations in AML
    • Authors: Guiqin Huang, Xiaoya Cai, Dengju Li
    • Year: 2024
    • DOI: 10.1007/s00277-024-05885-8
    • Citations: As this article was published in 2024, citation data may not be available yet.
  • An atypical patient with bone marrow failure syndrome‐2 without microcephaly and learning disability in a Chinese family
    • Authors: Jia Wu, Jin Wang, Ning Tang, Xiong Wang, Dengju Li
    • Year: 2023
    • DOI: 10.1111/bjh.18798
    • Citations: As this article was published in 2023, citation data may not be available yet.
  • The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial
    • Authors: Tingyu Wang, Xiuhua Sun, Lihua Qiu, Hang Su, Junning Cao, Zhiming Li, Yuqin Song, Li Zhang, Dengju Li, Huijing Wu, et al.
    • Year: 2023
    • DOI: 10.1158/1078-0432.c.6533216
    • Citations: As this article was published in 2023, citation data may not be available yet.